226950 — OliX Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩934bn
- KR₩962bn
- KR₩6bn
Annual cashflow statement for OliX Pharmaceuticals, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19,385 | -30,278 | -21,888 | -19,102 | -40,659 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4,219 | 7,592 | -1,945 | 3,203 | 11,624 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 10,266 | 2,002 | -8,925 | -7,912 | -1,637 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3,759 | -19,054 | -30,683 | -21,168 | -28,045 |
| Capital Expenditures | -1,162 | -26,285 | -2,535 | -9,068 | -14,080 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -30,258 | 41,758 | -52,229 | 43,435 | 15,053 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -31,420 | 15,473 | -54,764 | 34,366 | 974 |
| Financing Cash Flow Items | -55.2 | -3.53 | -166 | -128 | -15.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 41,660 | 26,555 | 56,048 | -6,110 | 18,541 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6,374 | 23,008 | -29,406 | 7,052 | -8,099 |